Asterias Biotherapeutics, Inc. Common Series A (AST)
Asterias Biotherapeutics, Inc. Common Series A (AST)
$0.94 USD
Updated Mar 7 8:00pm
Add AST to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
AST Stock Chart More Charts
AST Price/Volume Stats
| Current price | $0.94 |
| Prev. close | $0.95 |
| Day low | $0.90 |
| Day high | $0.95 |
| 50-day MA | $0.82 |
| 200-day MA | $1.25 |
| 52-week high | $2.05 |
| 52-week low | $0.51 |
| Volume | 99,200 |
| Avg. volume | 136,653 |
| Dividend yield | N/A |
| Market Cap | 52.32M |
Asterias Biotherapeutics, Inc. Common Series A (AST) Company Bio
Asterias Biotherapeutics, Inc., a biotechnology company, focuses on the emerging field of regenerative medicines. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. The company was founded in 2012 and is based in Fremont, California.
Top Stories View All
Best & Worst Performing Stock Industries for August 20, 2019
Best & Worst Performing Small Cap Stocks for August 20, 2019
Best & Worst Performing Mid Cap Stocks for August 20, 2019
Best & Worst Performing Mega Cap Stocks for August 20, 2019
Best & Worst Performing Large Cap Stocks for August 20, 2019
View All Top Stories
Loading social stream, please wait...